Results 161 to 170 of about 3,245 (193)

Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challenge. [PDF]

J Clin Invest
Chapman NS, Borisevich V, Kose N, Myers L, Priest S, Bergeron É, Trigo Esteban E, Sánchez-Seco MP, Melero J, Geisbert TW, Cross RW, Crowe JE.   +11 more
europepmc   +1 more source

Sero-epidemiology of Crimean-Congo haemorrhagic fever in mixed crop-livestock farming households in Burkina Faso: a one health study. [PDF]

PLoS One
Ilboudo AK, Dione M, Nijhof AM, Groschup MH, Cissé A, Lassane K, Savadogo M, Dahourou LD, Roesel K, Dabiré RK, Tarnagda Z, Bett B.   +11 more
europepmc   +1 more source

Prognostic Significance of CRP/Albumin, D-Dimer/Albumin, D-Dimer/Fibrinogen Ratios and Triglyceride-Glucose Index in Crimean-Congo Hemorrhagic Fever: A Prospective Observational Study. [PDF]

Trop Med Infect Dis
Aydın NN, Aydın M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Crimean-Congo hemorrhagic fever (CCHF) seroprevalence: A systematic review and meta-analysis

Acta Tropica, 2019
Crimean-Congo haemorrhagic fever (CCHF) is the most widespread, tick-borne viral disease affecting humans and therefore this paper performed a meta-analysis to highlight seroprevalence features of CCHF in a global context. After a preliminary review of the 396 papers representing areas throughout the world, 206 were selected for detailed meta-analysis.
Hassan Nasirian
exaly   +3 more sources

Recent outbreaks of crimean–congo hemorrhagic fever (CCHF) in Iraq

Science Archives, 2022
Crimean-Congo haemorrhagic fever (CCHF) is an emerging zoonotic disease defined as a disease that passes from an animal or insect to a human. It is responsible for several deaths in humans, while the hosts, like cows, sheep, and goats are not affected.
Dalal Al-Rubaye, Talib Saleh Al-Rubaye, Marwa Shaker, Hassan M Naif   +3 more
openaire   +1 more source

Crimean-Congo Hemorrhagic Fever [PDF]

Laboratory Medicine, 2015
The Crimean-Congo Hemorrhagic Fever (CCHF) is a tick-borne infectious viral disease in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. CCHF was then later recognized in 1969
Sadegh Chinikar, Chinikar Sadegh
exaly   +2 more sources

Crimean-Congo Hemorrhagic Fever (CCHF)

A and V Pub International Journal of Nursing and Medical Research, 2023
Crimean-Congo haemorrhagic fever (CCHF) is a viral infection that can kill a lot of people and is found in about 30 countries. It is the most widespread of the medically important diseases caused by ticks and is very close to how Hyalomma spp. ticks are found all over the world.
openaire   +1 more source

Immunosorbent Assays for Diagnosis of Crimean-Congo Hemorrhagic Fever (CCHF)

The American Journal of Tropical Medicine and Hygiene, 1982
Utilization of direct and indirect enzyme-linked immunosorbent assay (ELISA) and solid-phase radioimmunoassay (SPRIA) for the diagnosis of Crimean-Congo hemorrhagic fever (CCHF) allows the detection of low amounts of infectious virus (2 log LD50) or inactivated antigen and antibody to CCHF within 5-6 hours. These methods were shown to be more sensitive,
M A, Donets, G V, Rezapkin, A P, Ivanov, E A, Tkachenko   +3 more
openaire   +2 more sources